Skip to content

A Comparison Between TOF Watch® SX and Tetragraph®

A Comparison of Accelerometric Monitoring by TOF Watch® SX and Electromyographic Monitoring by Tetragraph® for Recovery From Neuromuscular Blockade

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04947306
Enrollment
20
Registered
2021-07-01
Start date
2020-08-24
Completion date
2020-10-30
Last updated
2021-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Blockade, Neuromuscular Monitoring

Brief summary

This observational study was designed to assess the agreement between the recently marketed electromyographic neuromuscular blockade monitor Tetragraph® (Senzime, Uppsala, Sweden) and the TOF Watch® SX (Organon Teknika B.V., Boxtel, Holland), an accelerometric neuromuscular blockade monitor frequently used in clinical practice

Detailed description

Before the induction of general anesthesia both monitors will be placed in the same arm. After induction of general anesthesia and before neuromuscular blocking agent administration both devices will be consecutively calibrated and a baseline measurement will be obtained. During the surgical procedure the investigators will monitor neuromuscular function with one of the two devices. Then the investigators will switch the device used as a guide between subsequent patients. The protocol will start as soon as the leading device will register a train-of-four ratio (TOFr) ≥ 0.2. During the protocol a comparison between the two devices will be conducted as soon as the device used as a guide will display a TOFr ≥ 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1. For each of the TOFr reported, we will deliver two subsequent TOF stimulations with the guiding device followed by two TOF stimulations with the other monitor. Both the stimulations delivered by each device and the two consecutive stimulations delivered by different monitors will be conducted 20 sec from one another. Stimulations with the same device will be used to assess intraobserver variability for each methodology, while the second and the third measurements (consecutive stimulations with different devices) will be used to assess agreement between them. The protocol will end when the leading device will show a TOFr ≥ 1.0, or if, at the end of the surgical procedure, acceleromyographic TOFr will be \> 0.9.

Interventions

DEVICETetragraph® (Senzime, Uppsala, Sweden)

The Tetragraph® is a recently marketed electromyographic neuromuscular monitor that uses a disposable electrode array (TetraSens) that combines stimulating and recording electrodes

DEVICETOF Watch® SX (Organon Teknika B.V., Boxtel, Holland)

The TOF Watch® SX is a common used neuromuscular monitor

Sponsors

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age \> 18 years * Rocuronium bromide use is anticipated for neuromuscular blockade during surgical procedure * Upper arms will be freely available during the surgical procedure

Exclusion criteria

* Known neuromuscular disease * Known allergy to Rocuronium bromide * end-stage liver disease * chronic kidney disease

Design outcomes

Primary

MeasureTime frameDescription
Agreement between TOF Watch® SX and Tetragraph® train-of-four ratiosRecovery from neuromuscular blockade at the end of the surgical procedureBias and Limits of Agreement between the two methodologies using Bland-Altman analysis

Secondary

MeasureTime frameDescription
Agreement between normalized TOF Watch® SX and Tetragraph® train-of-four ratiosRecovery from neuromuscular blockade at the end of the surgical procedureNormalized TOF Watch® SX train of four ratios will be calculated as the ratio between actual train-of-four ratio and baseline. Bias and Limits of Agreement will be derived using Bland-Altman analysis
Agreement between TOF Watch® SX and Tetragraph® train-of-four ratios for TOF ratios < 0.8Recovery from neuromuscular blockade at the end of the surgical procedureNormalized TOF Watch® SX train of four ratios will be calculated as the ratio between actual train-of-four ratio and baseline. Bias and Limits of Agreement will be derived using Bland-Altman analysis
Agreement between TOF Watch® SX and Tetragraph® train-of-four ratios for TOF ratios ≥ 0.8Recovery from neuromuscular blockade at the end of the surgical procedureNormalized TOF Watch® SX train of four ratios will be calculated as the ratio between actual train-of-four ratio and baseline. Bias and Limits of Agreement will be derived using Bland-Altman analysis
Absolute and relative intraobserver variability for TOF Watch® SX and Tetragraph®Recovery from neuromuscular blockade at the end of the surgical procedureAbsolute intraobserver variability will be calculated as the absolute difference between pairs of consecutive measurements by the same device. Relative intraobserver variability will be calculated as the ratio between the absolute difference and mean of the measurements.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026